Skip to main contentSkip to footer

A landmark decision for affordable tumour agnostic immunotherapy in Australia!

A landmark decision for affordable tumour agnostic immunotherapy in Australia! Congratulations to all involved.

Read the LinkedIn post

Previous Post
Webinar tomorrow: Immunotherapy broad PBS listing case study
Next Post
Roy Ramiscal to present at the Innovate Medtech Masterclasses